Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper, European Respiratory Journal, vol.23, issue.6, pp.932-946, 2004. ,
DOI : 10.1183/09031936.04.00014304
Global Initiative for Chronic Obstructive Lung Diseases (GOLD), Pulmonary Pharmacology & Therapeutics, vol.15, issue.4, pp.353-355, 2002. ,
DOI : 10.1006/pupt.2002.0381
Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review, BMC Medicine, vol.22, issue.Suppl 43, p.7, 2011. ,
DOI : 10.1136/thorax.58.5.388
URL : https://hal.archives-ouvertes.fr/inserm-00565204
Projections of Global Mortality and Burden of Disease from 2002 to 2030, PLoS Medicine, vol.52, issue.11, p.442, 2006. ,
DOI : 10.1371/journal.pmed.0030442.st007
Trends in the leading causes of death in the United States, pp.1255-1259, 1970. ,
Alternative projections of mortality and disability by cause 1990???2020: Global Burden of Disease Study, The Lancet, vol.349, issue.9064, pp.1498-1504, 1997. ,
DOI : 10.1016/S0140-6736(96)07492-2
International Primary Care Respiratory Group (IPCRG) Guidelines: Management of Chronic Obstructive Pulmonary Disease (COPD), Primary Care Respiratory Journal, vol.15, issue.1, pp.48-57, 2006. ,
DOI : 10.1016/j.pcrj.2005.11.003
Recommendations of the Francophone Society of Pneumology for pulmonary rehabilitation in COPD] [Article in French], Rev Mal Respir, vol.22, pp.696-704, 2005. ,
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study, The Lancet, vol.370, issue.9589, pp.741-750, 2007. ,
DOI : 10.1016/S0140-6736(07)61377-4
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study, The Lancet, vol.366, issue.9500, pp.1875-1881, 2005. ,
DOI : 10.1016/S0140-6736(05)67632-5
Causes of death: Standardised death rate (per 100,000 inhabitants) (Annual Data) ,
Prevalencia de bronquitis cr??nica, asma y obstrucci??n al flujo a??reo en una zona urbano-industrial de Catalu??a, Archivos de Bronconeumolog??a, vol.35, issue.3, pp.122-128, 1999. ,
DOI : 10.1016/S0300-2896(15)30290-8
Enfermedad pulmonar obstructiva cr??nica en la poblaci??n general. Estudio epidemiol??gico realizado en Guip??zcoa, Archivos de Bronconeumolog??a, vol.34, issue.1, pp.23-27, 1998. ,
DOI : 10.1016/S0300-2896(15)30501-9
Prevalencia de la enfermedad pulmonar obstructiva cr??nica y del asma. Estudio transversal, Archivos de Bronconeumolog??a, vol.30, issue.3, pp.149-152, 1994. ,
DOI : 10.1016/S0300-2896(15)31109-1
Patients ?? risque de broncho-pneumopathie chronique obstructive en m??decine g??n??rale, La Presse M??dicale, vol.34, issue.21, pp.1617-1622, 2005. ,
DOI : 10.1016/S0755-4982(05)84236-8
Chronic cough and phlegm in young adults, European Respiratory Journal, vol.22, issue.3, pp.413-417, 2003. ,
DOI : 10.1183/09031936.03.00121103
Chronic bronchitis among French adults: high prevalence and underdiagnosis, European Respiratory Journal, vol.20, issue.4, pp.806-812, 2002. ,
DOI : 10.1183/09031936.02.00042002
Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults, European Respiratory Journal, vol.18, issue.1, pp.85-92, 2001. ,
DOI : 10.1183/09031936.01.00087101
Primary care of the patient with chronic obstructive pulmonary disease in Italy, Respiratory Medicine, vol.103, issue.4, pp.582-588, 2009. ,
DOI : 10.1016/j.rmed.2008.10.017
Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. Chest, COPD prevalence in Salzburg, vol.131, pp.29-36, 2007. ,
Obstructive airways diseases, smoking and use of inhaled corticosteroids in southern Sweden in, Int J Tuberc Lung Dis, vol.10, pp.490-498, 1992. ,
Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study, International Journal of Epidemiology, vol.28, issue.4, pp.717-722, 1999. ,
DOI : 10.1093/ije/28.4.717
Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden, Respiratory Medicine, vol.92, issue.12, pp.1337-1345, 1998. ,
DOI : 10.1016/S0954-6111(98)90139-1
Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey, Eur Respir J, vol.4, pp.257-266, 1991. ,
Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities, Thorax, vol.64, issue.10, pp.863-868, 2009. ,
DOI : 10.1136/thx.2009.115725
Prevalence, Incidence, and Lifetime Risk for the Development of COPD in the Elderly, Chest, vol.135, issue.2, pp.368-377, 2009. ,
DOI : 10.1378/chest.08-0684
The Prevalence of Chronic Obstructive Pulmonary Disease among Danes Aged 45???84 Years: Population-based Study, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.169, issue.6, pp.347-352, 2008. ,
DOI : 10.1136/bmj.324.7350.1370
Prevalence, severity and underdiagnosis of COPD in the primary care setting, Thorax, vol.63, issue.5, pp.402-407, 2008. ,
DOI : 10.1136/thx.2007.085456
Impact of chronic airflow obstruction in a working population, European Respiratory Journal, vol.31, issue.6, pp.1227-1233, 2008. ,
DOI : 10.1183/09031936.00089607
Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample, Thorax, vol.61, issue.12, pp.1043-1047, 2006. ,
DOI : 10.1136/thx.2006.064410
Can Global Initiative for Chronic Obstructive Lung Disease stage 0 provide prognostic information on long-term mortality in men? Chest, pp.318-325, 2006. ,
Prevalence of Chronic Obstructive Pulmonary Disease and Rhinitis in Northern Greece, Respiration, vol.72, issue.3, pp.270-277, 2005. ,
DOI : 10.1159/000085368
The prevalence of obstructive lung disease in a general population sample: The NICECOPD study, European Journal of Epidemiology, vol.9, issue.suppl 5, pp.443-453, 2005. ,
DOI : 10.1007/s10654-005-1248-8
Prevalence of COPD in Greece, Chest, vol.125, issue.3, pp.892-900, 2004. ,
DOI : 10.1378/chest.125.3.892
Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care, Scandinavian Journal of Primary Health Care, vol.19, issue.1 ,
DOI : 10.1080/028134301300034701
Geographic Variations in Prevalence and Underdiagnosis of COPD, Chest, vol.118, issue.4, pp.981-989, 2000. ,
DOI : 10.1378/chest.118.4.981
Prevalence of Airways Obstruction in a General Population, Chest, vol.117, issue.5, pp.339-345, 2000. ,
DOI : 10.1378/chest.117.5_suppl_2.339S
Screening older patients for obstructive airways disease in a semi-rural practice, Thorax, vol.54, issue.6, pp.501-505, 1999. ,
DOI : 10.1136/thx.54.6.501
Prevalence and treatment of chronic airways obstruction in adults over the age of 45., Thorax, vol.51, issue.2, pp.164-168, 1996. ,
DOI : 10.1136/thx.51.2.164
Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents., Thorax, vol.46, issue.12, pp.863-870, 1991. ,
DOI : 10.1136/thx.46.12.863
COPD: A prevalence estimation model, Respirology, vol.134, issue.5, pp.594-602, 2005. ,
DOI : 10.1378/chest.117.2_suppl.5S
The Impact of Aging and Smoking on the Future Burden of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.164, issue.4, pp.590-596, 2001. ,
DOI : 10.1164/ajrccm.164.4.2003167
The Prevalence of COPD, Chest, vol.117, issue.5, pp.354-359, 2000. ,
DOI : 10.1378/chest.117.5_suppl_2.354S
Optimal assessment and management of chronic obstructive pulmonary disease (COPD), European Respiratory Journal, vol.8, issue.8, pp.1398-1420, 1995. ,
DOI : 10.1183/09031936.95.08081398
Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review, BMC Medicine, vol.22, issue.Suppl 43, p.7, 2011. ,
DOI : 10.1136/thorax.58.5.388
URL : https://hal.archives-ouvertes.fr/inserm-00565204
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.6, pp.532-555, 2007. ,
DOI : 10.1164/rccm.200703-456SO
Corrigendum to: ???Prevalence and underdiagnosis of COPD by disease severity and attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden Studies???, Respiratory Medicine, vol.101, issue.12, pp.264-272, 2006. ,
DOI : 10.1016/j.rmed.2007.07.019
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages, Thorax, vol.59, issue.2, pp.120-125, 2004. ,
DOI : 10.1136/thorax.2003.011163
Costs of COPD in Sweden According to Disease Severity, Chest, vol.122, issue.6, pp.1994-2002, 2002. ,
DOI : 10.1378/chest.122.6.1994
Airway obstruction in relation to symptoms in chronic respiratory disease???a nationally representative population study, Respiratory Medicine, vol.94, issue.4, pp.356-363, 2000. ,
DOI : 10.1053/rmed.1999.0715
Study of the burden on patients with chronic obstructive pulmonary disease, International Journal of Clinical Practice, vol.166, issue.Suppl. 2, pp.87-97, 2009. ,
DOI : 10.1111/j.1742-1241.2008.01936.x
Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice, Respiratory Medicine, vol.100, issue.1, pp.83-86, 2006. ,
DOI : 10.1016/j.rmed.2005.04.004
The SCOPE Study: Health-Care Consumption Related to Patients with Chronic Obstructive Pulmonary Disease in France, Value in Health, vol.7, issue.2, pp.168-174, 2004. ,
DOI : 10.1111/j.1524-4733.2004.72329.x
Recent trends in physician diagnosed COPD in women and men in the UK, Thorax, vol.55, issue.9, pp.789-794, 2000. ,
DOI : 10.1136/thorax.55.9.789
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease, Thorax, vol.60, issue.11, pp.925-931, 2005. ,
DOI : 10.1136/thx.2005.040527
Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions?, Respiratory Medicine, vol.98, issue.2, pp.178-183, 2004. ,
DOI : 10.1016/j.rmed.2003.09.011
Newly Diagnosed Chronic Obstructive Pulmonary Disease, Respiration, vol.70, issue.1, pp.67-75, 2003. ,
DOI : 10.1159/000068417
Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study, Thorax, vol.58, issue.8, pp.654-658, 2003. ,
DOI : 10.1136/thorax.58.8.654
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial, The Lancet, vol.361, issue.9356, pp.449-456, 2003. ,
DOI : 10.1016/S0140-6736(03)12459-2
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations, European Respiratory Journal, vol.21, issue.1, pp.68-73, 2003. ,
DOI : 10.1183/09031936.03.00013303
The costs of exacerbations in chronic obstructive pulmonary disease (COPD), Respiratory Medicine, vol.96, issue.9, pp.700-708, 2002. ,
DOI : 10.1053/rmed.2002.1334
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial, BMJ, vol.320, issue.7245, pp.1297-1303, 2000. ,
DOI : 10.1136/bmj.320.7245.1297
(Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study, Thorax, vol.64, issue.11, pp.956-962, 2009. ,
DOI : 10.1136/thx.2008.112243
Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial, Respiratory Research, vol.365, issue.8, p.69, 2009. ,
DOI : 10.1016/S0140-6736(05)66456-2
Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis, Respiratory Medicine, vol.103, issue.4, pp.542-551, 2009. ,
DOI : 10.1016/j.rmed.2008.11.003
Defining COPD exacerbations: impact on estimation of incidence and burden in primary care, Primary Care Respiratory Journal, vol.15, issue.6, pp.346-353, 2006. ,
DOI : 10.1016/j.pcrj.2006.08.009
Decline in Patients with Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.8, pp.871-876, 2006. ,
DOI : 10.1164/rccm.200509-1489OC
Longitudinal changes in the nature, severity and frequency of COPD exacerbations, European Respiratory Journal, vol.22, issue.6, pp.931-936, 2003. ,
DOI : 10.1183/09031936.03.00038303
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.161, issue.5, pp.1608-1613, 2000. ,
DOI : 10.1164/ajrccm.161.5.9908022
Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations, American Journal of Respiratory and Critical Care Medicine, vol.178, issue.11, pp.1139-1147, 2008. ,
DOI : 10.1164/rccm.200801-145OC
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.359, issue.15, pp.1543-1554, 2008. ,
DOI : 10.1056/NEJMoa0805800
One-year treatment with mometasone furoate in chronic obstructive pulmonary disease, Respiratory Research, vol.58, issue.10, p.73, 2008. ,
DOI : 10.1136/thorax.58.10.855
The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.1, pp.19-26, 2008. ,
DOI : 10.1164/rccm.200707-973OC
The effect of tiotropium on exacerbations and airflow in patients with COPD, European Respiratory Journal, vol.27, issue.3, pp.547-555, 2006. ,
DOI : 10.1183/09031936.06.00062705
ipratropium to treat chronic obstructive pulmonary disease, European Respiratory Journal, vol.23, issue.2, pp.241-249, 2004. ,
DOI : 10.1183/09031936.03.00083703
Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD, Thorax, vol.58, issue.5, pp.399-404, 2003. ,
DOI : 10.1136/thorax.58.5.399
A Computer Simulation Model of the Natural History and Economic Impact of Chronic Obstructive Pulmonary Disease, Value in Health, vol.7, issue.2, pp.153-167, 2004. ,
DOI : 10.1111/j.1524-4733.2004.72318.x
The Impact of COPD on Lung Health Worldwide, Chest, vol.117, issue.2, pp.1-4, 2000. ,
DOI : 10.1378/chest.117.2_suppl.1S
Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD*, Chest, vol.124, issue.2, pp.459-467, 2003. ,
DOI : 10.1378/chest.124.2.459
Mortality After Hospitalization for COPD, Chest, vol.121, issue.5, pp.1441-1448, 2002. ,
DOI : 10.1378/chest.121.5.1441
Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity, Respiratory Research, vol.350, issue.Suppl 5, p.109, 2006. ,
DOI : 10.1056/NEJMoa021322
How often is diagnosis of COPD confirmed with spirometry?, Respiratory Medicine, vol.104, issue.4, pp.550-556, 2010. ,
DOI : 10.1016/j.rmed.2009.10.023
Derivation and Validation of a Composite Index of Severity in Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.180, issue.12, pp.1189-1195, 2009. ,
DOI : 10.1164/rccm.200902-0271OC
Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index, The Lancet, vol.374, issue.9691, pp.704-711, 2009. ,
DOI : 10.1016/S0140-6736(09)61301-5
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials, Thorax, vol.63, issue.2, pp.122-128, 2008. ,
DOI : 10.1136/thx.2007.082636
Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review, BMC Medicine, vol.22, issue.Suppl 43, p.7, 2011. ,
DOI : 10.1136/thorax.58.5.388
URL : https://hal.archives-ouvertes.fr/inserm-00565204
Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates, Natl Vital Stat Rep, vol.49, pp.1-32, 2001. ,
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study, Thorax, vol.58, issue.5, pp.388-393, 2003. ,
DOI : 10.1136/thorax.58.5.388
The burden of lung disease in Europe, 2003. ,
The pharmacoepidemiology of COPD: recent advances and methodological discussion, Eur Respir J, pp.2241-2285, 2003. ,
Cite this article as Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review, BMC Medicine, p.7, 2011. ,
Chronic Obstructive Pulmonary Disease; NS, Not specified.! * Symptoms correspond to cough and sputum at least 3 months each year. These patients had chronic bronchitis.! ? Functional respiratory tests: FEV1/FVC<70% and FEV1<80% of predicted or FEV1/FVC<65% or FEV1/FVC<70% or FEV1/FVC< 88% (male)/ 89% (female)! ? Abbreviations for countries: United Kingdom; EU, 16 European Union Countries.! § Abbreviations for types of population: GP, general population; HP, health prevention center; TP, total population; OC, occupational cohort; PC, primary care.! # Age was reported in various ways distinguished here as follows: !? x", minimum age; "x" or "x(y)", mean age or mean age (SD); "{x-y}", age range i.e. {min-max}.! ? These data are also reported in Schirnhofer! ** Prevalence estimates based on the European Respiratory Society?s statement or based on " clinical " criteria (FEV1/FVC < 70%) correspond to 11% and 18, 3%, respectively.! 0%! 20%! 40%! 60%! 80%! 100%! AT, pp.14-51, 2000. ,
Text abbreviations: COPD, Chronic Obstructive Pulmonary Disease; GPCS, General Practitioner and/or Chest Specialist.! *Abbreviations for countries: AT, Austria, 16 European Union Countries.! ?Abbreviations for classifications: ERS, 1995. ,
classifications only define three stages.! §In this study, based on GOLD 2003 severity scale, the estimates in stage 0 defining persons at risk of COPD ranged from 51.7% in Switzerland to 89.8% in Spain.! #Persons with both FEV1/FVC<70% and FEV1?80% (considered as having COPD in the GOLD 2006 classification but not in the BTS 1995 classification) were also included in the study.! ?Airway obstruction of any degree was defined by FEV1/FVC<70% and the severity of obstruction was graded according to the FEV1 value: mild (FEV1?70% of predicted) and moderate-severe, 1995. ,
80% and the severity of obstruction was graded according to the FEV1/FVC value: 70-79%, minimal to mild; 50-69%, moderate; <50%, severe.! Males! Females! -40! -20! 0! 20! 40! 60!, 1988. ,
year(s)! ,
associated codes were used: [10], version 10 and codes J40?J44 and J47 (excepted for Greece where the estimates correspond to codes J40?J47); [45], version 9 and codes 490?493; [78], version 9 and codes 490-496. ! COPD, Chronic Obstructive Pulmonary Disease.! Abbreviations for countries, the three mentioned references, the following versions of the International Classification of the Disease and ,